Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053947727> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2053947727 endingPage "489" @default.
- W2053947727 startingPage "479" @default.
- W2053947727 abstract "The Hartree-Fock ab initio molecular orbital method has been applied to eight compounds: GABA (gamma-amino butyric acid) (1), its partially rigidified analog, TACA (trans-4-aminocrotonic acid) (2), six isoxazolol analogs; muscimol (5-aminomethylisoxazol-3-ol (3), THIP (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) (4), THAZ (5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol) (5), isomuscimol (3-aminomethylisoxazol-5-ol) (6), iso-THIP (4,5,6,7-tetrahydroisoxazolo[3,4-c]pyridin-5-ol) (7), and iso-THAZ (5,6,7,8-tetrahydro-4H-isoxazolo[3,4-d]azepin-5-ol) (8). GABA is an endogenous inhibitory transmitter. The four following molecules (2), (3), (4) and (5) are agonist: they bind themselves to the GABA receptors and induce approximately the same effect as GABA. (6) is lightly agonist, presenting a lower affinity. Compounds (7) and (8) are antagonists, giving rise to convulsion. Optimized molecular conformations of GABA (1), muscimol (3) and isomuscimol (6) are discussed. Geometric and electronic parameters showing the presence of intramolecular hydrogen bonds are presented. The permutation of the heteroatoms in the isoxazole ring has no effect on the side-chain orientation explaining maybe the agonist character of isomuscimol, being able to adopt easily and exactly the active conformation. Atomic charge distributions and electronic overlap populations for all compounds have been computed in order to try to understand why their GABAergic activities can be so different. The computed values show that the 3-isoxazolol ring mimics in a good way the carboxylic function of GABA. They also illustrate the larger electronic delocalization within the 5-isoxazolol ring and therefore the resulting antagonist character, except for isomuscimol." @default.
- W2053947727 created "2016-06-24" @default.
- W2053947727 creator A5020210539 @default.
- W2053947727 creator A5025970115 @default.
- W2053947727 creator A5074836866 @default.
- W2053947727 creator A5082500353 @default.
- W2053947727 date "1987-08-01" @default.
- W2053947727 modified "2023-10-18" @default.
- W2053947727 title "3- and 5-Isoxazolol zwitterions: an ab initio molecular orbital study relating to GABA agonism and antagonism" @default.
- W2053947727 cites W1558658435 @default.
- W2053947727 cites W1979313965 @default.
- W2053947727 cites W1986619553 @default.
- W2053947727 cites W2006787354 @default.
- W2053947727 cites W2014774246 @default.
- W2053947727 cites W2057979708 @default.
- W2053947727 cites W2066628109 @default.
- W2053947727 cites W2085753563 @default.
- W2053947727 cites W2093147008 @default.
- W2053947727 cites W2115878464 @default.
- W2053947727 cites W2329898820 @default.
- W2053947727 cites W2416418464 @default.
- W2053947727 cites W2083957574 @default.
- W2053947727 doi "https://doi.org/10.1016/s0022-5193(87)80144-3" @default.
- W2053947727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2832660" @default.
- W2053947727 hasPublicationYear "1987" @default.
- W2053947727 type Work @default.
- W2053947727 sameAs 2053947727 @default.
- W2053947727 citedByCount "11" @default.
- W2053947727 countsByYear W20539477272014 @default.
- W2053947727 countsByYear W20539477272016 @default.
- W2053947727 crossrefType "journal-article" @default.
- W2053947727 hasAuthorship W2053947727A5020210539 @default.
- W2053947727 hasAuthorship W2053947727A5025970115 @default.
- W2053947727 hasAuthorship W2053947727A5074836866 @default.
- W2053947727 hasAuthorship W2053947727A5082500353 @default.
- W2053947727 hasConcept C112887158 @default.
- W2053947727 hasConcept C168258287 @default.
- W2053947727 hasConcept C170493617 @default.
- W2053947727 hasConcept C178790620 @default.
- W2053947727 hasConcept C185592680 @default.
- W2053947727 hasConcept C2778938600 @default.
- W2053947727 hasConcept C2779188335 @default.
- W2053947727 hasConcept C2781442258 @default.
- W2053947727 hasConcept C32909587 @default.
- W2053947727 hasConcept C55493867 @default.
- W2053947727 hasConcept C71240020 @default.
- W2053947727 hasConcept C75079739 @default.
- W2053947727 hasConceptScore W2053947727C112887158 @default.
- W2053947727 hasConceptScore W2053947727C168258287 @default.
- W2053947727 hasConceptScore W2053947727C170493617 @default.
- W2053947727 hasConceptScore W2053947727C178790620 @default.
- W2053947727 hasConceptScore W2053947727C185592680 @default.
- W2053947727 hasConceptScore W2053947727C2778938600 @default.
- W2053947727 hasConceptScore W2053947727C2779188335 @default.
- W2053947727 hasConceptScore W2053947727C2781442258 @default.
- W2053947727 hasConceptScore W2053947727C32909587 @default.
- W2053947727 hasConceptScore W2053947727C55493867 @default.
- W2053947727 hasConceptScore W2053947727C71240020 @default.
- W2053947727 hasConceptScore W2053947727C75079739 @default.
- W2053947727 hasIssue "4" @default.
- W2053947727 hasLocation W20539477271 @default.
- W2053947727 hasLocation W20539477272 @default.
- W2053947727 hasOpenAccess W2053947727 @default.
- W2053947727 hasPrimaryLocation W20539477271 @default.
- W2053947727 hasRelatedWork W1545393884 @default.
- W2053947727 hasRelatedWork W1550806868 @default.
- W2053947727 hasRelatedWork W2002731382 @default.
- W2053947727 hasRelatedWork W2013312804 @default.
- W2053947727 hasRelatedWork W2033069720 @default.
- W2053947727 hasRelatedWork W2046854938 @default.
- W2053947727 hasRelatedWork W2087746615 @default.
- W2053947727 hasRelatedWork W2336398859 @default.
- W2053947727 hasRelatedWork W2337133993 @default.
- W2053947727 hasRelatedWork W4247942854 @default.
- W2053947727 hasVolume "127" @default.
- W2053947727 isParatext "false" @default.
- W2053947727 isRetracted "false" @default.
- W2053947727 magId "2053947727" @default.
- W2053947727 workType "article" @default.